IT

Istituto Europeo di Oncologia Srl

Horizon Europe
ieo.itCompare
18
Projects
3
Coordinated
10
As Partner
€1,227,464
Total Budget

Budget Range

Min
€1,500
Average
€68,192
Max
€299,357

Role Distribution

Sector Distribution

Budget by Sector (€)

Projects (18)

P

UNCAN-CONNECT: Decentralized Collaborative Network for Advancing Cancer Research and Innovation

Health101215206
€299,357
P

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

Health101218845
€126,000
P

Impact of cell shapes on cell behaviour and fate

ERC (European Research Council)101071470
€108,348
P

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Health101096362
€106,073
P

Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy

Health101057695
€99,967
P

European Cohorts of Patients and Schools to Advance Response to Epidemics

HORIZON.2.1101046016
€99,959
P

Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

Health101136953
€79,999
P

Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach

Health101214326
€62,397
P

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Health101104269
€59,687
C

IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION: AN INTEGRATED PLATFORM TO PROMOTE BEHAVIOURAL CHANGE

Health101136840
€57,500
P

METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY

MSCA (Marie Skłodowska-Curie)101166838
€40,237
P

A training network on glyconanomaterials as precision tools to unveil key insights on the triggering of the antigen presenting cells against cancer

HORIZON.1.2101226412
€40,175
P

Development and validation of a pan-cancer neutrophil biomarker test for predicting clinical benefit from immunotherapy based on flow cytometry analysis of blood samples

HORIZON.3.1101213660
€25,000
P

Patient-specific Microstructural and radIobiological model for persoNalised external beam radiatIONn therapy in localised tumourS

HORIZON.1.1101116811
€14,877
P

Understanding Nanoparticle Transport Mechanisms in the Melanoma Microenvironment via a Tumor-on-a-Chip Approach

MSCA (Marie Skłodowska-Curie)101205238
€2,357
C

Exploring silencer functions via their associated chromatin factors

MSCA (Marie Skłodowska-Curie)101203036
€2,095
C

iINGUT: immunotherapy on an INtegrated GUt microbiome and Tumor on-chip.

MSCA (Marie Skłodowska-Curie)101205004
€1,936
C

Targeting the Polycomb Machinery in BAP1-related Pathologies

HORIZON.1.1101111993
€1,500